Jonathan W. Friedberg, MD, MMSc, is a medical oncologist with subspecialty expertise in lymphoma. He serves as Director of the Wilmot Cancer Institute at the University of Rochester Medical Center and holds the Samuel Durand Professorship of Medicine. Clinically, he focuses on hematologic malignancies, cellular therapies and stem cell transplantation, and multidisciplinary cancer care. His research interests include therapeutic development and practice-changing clinical trials in hematologic cancers, cellular immunotherapy and transplant strategies, and precision oncology and novel targeted agents. An internationally recognized leader, Dr. Friedberg is editor-in-chief of the Journal of Clinical Oncology, chairs the lymphoma committee in the SWOG Cancer Research Network, co-leads a North American intergroup initiative in advanced-stage Hodgkin lymphoma, and serves on the Lymphoma Steering Committee. His honors include the Scholar in Clinical Research award from the Leukemia & Lymphoma Society and the Faculty Academic Mentoring Award from the University of Rochester School of Medicine and Dentistry. He earned his MD and MMSc at Harvard Medical School, completed internal medicine training at Massachusetts General Hospital, and a Hematology/Oncology fellowship at Dana-Farber/Partners Cancer Care.
Hospital Leadership
Medical School
1994
Residency
1994 – 1997
Fellowship
1997 – 1999